CVS, Walgreens Want Out Of Blood Pressure Drug MDL

By Daphne Zhang · July 20, 2020, 11:22 PM EDT

Pharmacies including CVS and Walgreens have urged a New Jersey federal judge to drop them from multidistrict litigation alleging they misrepresented a generic high blood pressure drug, arguing that the allegations...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION

Case Number

Court

New Jersey

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

February 14, 2019

Recent Articles By Daphne

January 25, 2022
How Vaccine Mandates Impact Employment Insurance Policies
January 14, 2022
War Exclusion Doesn't Bar Merck's $1.4B Cyber Loss
November 19, 2021
Insurers Have Edge In Georgia COVID-19 Coverage Fights
October 20, 2021
Chubb Can't Sidestep Settlement For Canceled Trade Show
October 08, 2021
Judge Blocks Insurer's Appeal Bid Over Duke's Antitrust Suits
September 01, 2021
Endo Beats Investors' Opioid Crisis Class Suit, For Now
August 31, 2021
Cincinnati Notches Virus Coverage Win At 11th Circ.
July 27, 2021
NY's Biggest Health System Loses COVID-19 Coverage Suit
July 26, 2021
2nd. Circ. Upholds Insurer's Win On NYU Storm Coverage
July 22, 2021
Barnes & Thornburg Adds 2 Insurance Attys From Reed Smith